Antoni TorresSpringer USEwig S, Torres A. Pseudomonas aeruginosa and initial antibiotic choices. In: Rello J, Leeper K, eds. Perspectives on Severe Community-Acquired Pneumonia. Nor- well, Mass: Kluwer Academic Publishers. 2001:105-118.
Pseudomonas aeruginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janei... This study had the objective of to analyze the demographic and bacteriologic data of 32 hospitalized newborns in an neonatal intensive care ...
Epidemiological studies have shown that nearly 700,000 people died of the antibiotic resistance bacterial infections each year.P. aeruginosathat was isolated from European populations with a combined resistance was 12.9%.9Hospital-acquired infection caused byP. aeruginosacontinues to produce resistance to ...
Pseudomonas aeruginosa 是导致在患上呼吸道疾病的病人中的一生威胁感染的一只重要病菌。这些感染很难对待,部分由于到临床上被使用的抗菌素的细菌的高本质的抵抗和部分由于抗菌容忍的生物电影的构成。Biofilms 为不同于浮游生物的细胞的那些的确切的基因所熟知,他们通常据信密切地类似于在固定局面中的浮游生物的细胞 (1...
A transcriptomics approach was used to identify genes differentially regulated during biofilm growth of Pseudomonas aeruginosa. These genes were tested for statistically significant overlap with independently compiled gene lists corresponding to stress responses and other putative antibiotic protective mechanisms....
2. Virulence determinants of P. aeruginosa 3. Significance biofilm formation in P. aeruginosa 4. Antibiogram of P. aeruginosa 5. Pseudomonas aeruginosa antibiotic resistance genes (ARGs) 6. The link between the accessory genome and resistance dissemination in P. aeruginosa 7. Methods of treatment...
time, andP. aeruginosaisolates from the final lung sample were above the EUCAST clinical breakpoint for meropenem resistance (red dashed line). Amoxicillin clavulanate resistance was not measured as this antibiotic is not active againstP. aeruginosa. Source data are provided as a Source Data file....
Journal of Biological ChemistryHays EE, Wells IC, Katzman PA, Cain CK, Jacobs FA, Thayer SA, Doisy EA, Gaby WL, Roberts EC, Muir RD, Carroll CJ, Jones LR, Wade NJ (1945) Antibiotic substances produced by Pseudomonas aeruginosa. J Biol Chem 159:725-750...
Narrow-spectrum antibiotic exploits metabolic differences to inhibit Pseudomonas aeruginosa. Nat Microbiol 9, 1165–1166 (2024). https://doi.org/10.1038/s41564-024-01673-2 Download citation Published19 April 2024 Issue DateMay 2024 DOIhttps://doi.org/10.1038/s41564-024-01673-2 Subjects Antibiotics...
Tobramycin is the antibiotic of choice in P. aeruginosa infections, but outcomes are variable (Mulcahy et al., 2014). At 6 h post-infection, tobramycin was started every day for 1 week but had little effect on the clearance of the P. aeruginosa biofilm (Figures 5A and 5B). In fact, ...